| scholarly article | Q13442814 |
| P50 | author | David J Salant | Q56670579 |
| P2093 | author name string | Laurence H Beck | |
| Jean M Francis | |||
| P2860 | cites work | Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor | Q24339583 |
| M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy | Q24652978 | ||
| Membranous nephropathy: not just a disease for adults | Q26866206 | ||
| Extended and bent conformations of the mannose receptor family | Q28264568 | ||
| Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy | Q28943554 | ||
| Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy | Q33660542 | ||
| Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy | Q34008949 | ||
| Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan | Q34221532 | ||
| PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system | Q34338687 | ||
| M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy | Q34455214 | ||
| Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy | Q34701007 | ||
| Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy | Q34783516 | ||
| Anti-phospholipase A2 receptor antibody in membranous nephropathy | Q35012441 | ||
| Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy | Q35027267 | ||
| Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy | Q35030567 | ||
| Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy | Q35142743 | ||
| Recurrent glomerulonephritis following renal transplantation: an update | Q35155013 | ||
| Antiphospholipase A₂ receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy | Q35165809 | ||
| Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy | Q35755581 | ||
| Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy | Q35782970 | ||
| Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy | Q35977341 | ||
| Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases | Q36009282 | ||
| Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy | Q36104805 | ||
| Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy | Q36280364 | ||
| The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border | Q36312050 | ||
| Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats | Q36347427 | ||
| Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane | Q36353772 | ||
| Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy | Q36719250 | ||
| Experimental glomerulonephritis in the isolated perfused rat kidney | Q37034118 | ||
| Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy | Q37078429 | ||
| Pathogenesis of membranous nephropathy: recent advances and future challenges | Q37988806 | ||
| De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease? | Q38036393 | ||
| Glomerular diseases: membranous nephropathy--a modern view | Q38118221 | ||
| Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA loci | Q38343858 | ||
| Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy | Q38399066 | ||
| Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy | Q39476063 | ||
| Strong association between idiopathic membranous nephropathy and HLA-DRW3 | Q39568654 | ||
| Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis | Q39850573 | ||
| The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review | Q40641817 | ||
| Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy | Q41123392 | ||
| Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy | Q41659143 | ||
| Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues | Q42588842 | ||
| Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy | Q43123391 | ||
| Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy. | Q43468343 | ||
| The ERA-EDTA Database on Recurrent Glomerulonephritis following renal transplantation. | Q43612061 | ||
| Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy? | Q43973401 | ||
| Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy | Q45350198 | ||
| De novo membranous nephropathy associated with donor-specific alloantibody | Q46792984 | ||
| Very Early Recurrence of Anti-Phospholipase A2 Receptor-Positive Membranous Nephropathy After Transplantation | Q57193559 | ||
| Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy | Q57371055 | ||
| Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN) | Q60729404 | ||
| Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase Antibodies | Q61849375 | ||
| Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis | Q67516884 | ||
| A DQA1 allele is strongly associated with idiopathic membranous nephropathy | Q69378963 | ||
| HLA-DR3 and idiopathic membranous nephritis (IMN) association | Q71626222 | ||
| In situ immune complex formation and glomerular injury | Q72133665 | ||
| Characterization of the antigen (gp600) of Heymann nephritis | Q72725850 | ||
| Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors | Q77425413 | ||
| Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study | Q81180642 | ||
| Increased risk of recurrence of membranous nephropathy after related donor kidney transplantation | Q82329168 | ||
| De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney | Q83199466 | ||
| PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy | Q83416838 | ||
| C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury | Q83828722 | ||
| An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis | Q84246189 | ||
| Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy | Q84311459 | ||
| Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy | Q84728773 | ||
| Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies | Q84758630 | ||
| Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy | Q84968205 | ||
| PLA2R Autoantibodies and Recurrent Membranous Nephropathy after Transplantation | Q84984695 | ||
| Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up | Q85239479 | ||
| Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies | Q85574653 | ||
| Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy | Q85946597 | ||
| Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1 | Q86056184 | ||
| Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy | Q86439847 | ||
| Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy | Q86509526 | ||
| Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy | Q86714243 | ||
| Treatment of idiopathic membranous nephropathy | Q87035617 | ||
| Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients | Q87447195 | ||
| Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy | Q87680047 | ||
| P433 | issue | 1 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 138-147 | |
| P577 | publication date | 2016-04-13 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Membranous Nephropathy: A Journey From Bench to Bedside | |
| P478 | volume | 68 |
| Q47744875 | Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy |
| Q64916886 | Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy. |
| Q58083355 | Association between the HLA-DQA1 rs2187668 polymorphism and risk of idiopathic membranous nephropathy: A PRISMA-compliant meta-analysis |
| Q59807182 | Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey |
| Q90004098 | Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy |
| Q47962363 | Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy |
| Q92411356 | Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study |
| Q47740261 | Clinicopathological and long-term prognostic features of membranous nephropathy with crescents: a Japanese single-center experience |
| Q38821066 | Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology |
| Q104472868 | Functional Magnetic Resonance Imaging Versus Kidney Biopsy to Assess Response to Therapy in Nephrotic Syndrome: A Case Report |
| Q49215238 | ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap. |
| Q92550620 | Immunology of membranous nephropathy |
| Q52670774 | Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management. |
| Q38959093 | Membranous nephropathy in the kidney allograft |
| Q101457844 | Meta-Analysis of the Diagnostic Efficiency of THSD7A-AB for the Diagnosis of Idiopathic Membranous Nephropathy |
| Q99711500 | Myeloid-Derived Suppressor Cells Promote the Progression of Primary Membranous Nephropathy by Enhancing Th17 Response |
| Q39412533 | PLA2R and THSD7A: Disparate Paths to the Same Disease? |
| Q38760741 | Primary Membranous Nephropathy |
| Q99584644 | Profile of Indian Patients With Membranous Nephropathy |
| Q57489227 | Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report |
| Q41083693 | Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study |
| Q100490958 | The tissue proteome in the multi-omic landscape of kidney disease |
| Q55483623 | The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation. |
| Q47835456 | Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review |
| Q52694933 | Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis. |
Search more.